Emergent BioSolutions Inc. (EBS)

NYSE: EBS · Real-Time Price · USD

8.92

-0.07 (-0.78%)

Mar 3, 2026, 4:00 PM EST - Market closed

Revenue by Segment

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Commercial Products	226.10M	398.90M	497.30M	386.60M	438.00M
Commercial Products Growth	-43.32%	-19.79%	28.63%	-11.74%	-
Mcm Products	456.70M	509.80M	447.20M	579.60M	585.90M
Mcm Products Growth	-10.42%	14.00%	-22.84%	-1.08%	-
All Other	60.10M	134.90M	104.80M	-	-
All Other Growth	-55.45%	28.72%	-	-	-
Services	-	-	-	109.90M	615.50M
Services Growth	-	-	-	-82.14%	30.29%
Unallocated Contracts and Grants	-	-	-	41.40M	134.20M
Unallocated Contracts and Grants Growth	-	-	-	-69.15%	16.59%
Total	742.90M	1.04B	1.05B	1.12B	1.77B
Total Growth	-28.81%	-0.54%	-6.10%	-36.99%	12.45%

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
United States	531.10M	822.60M	607.20M	886.10M	1.62B
United States Growth	-35.44%	35.47%	-31.48%	-45.42%	10.59%
Canada	75.00M	140.40M	224.20M	148.60M	66.70M
Canada Growth	-46.58%	-37.38%	50.87%	122.79%	45.00%
Other	136.80M	80.60M	217.90M	82.80M	83.50M
Other Growth	69.73%	-63.01%	163.16%	-0.84%	31.70%
Total	742.90M	1.04B	1.05B	1.12B	1.77B
Total Growth	-28.81%	-0.54%	-6.10%	-36.99%	12.45%

Source: S&P Global Market Intelligence.